ASX
Paradigm Biopharmaceuticals Limited
PAR:ASX•Healthcare
Sensitive ASX Announcement
First Participant Dosed in PARs Phase 2b OA Clinical Trial
Published: 30/10/17, 08:39am (AEST)•4 pages